April 24, 2020 / 1:27 PM / a month ago

BRIEF-Janssen Submits Two Applications To FDA Seeking Approval Of Simponi Aria® To Treat Polyarticular Juvenile Idiopathic Arthritis And Juvenile Psoriatic Arthritis

April 24 (Reuters) - Johnson & Johnson:

* JANSSEN ANNOUNCES SUBMISSION OF TWO APPLICATIONS TO U.S. FDA SEEKING APPROVAL OF SIMPONI ARIA® (GOLIMUMAB) FOR THE TREATMENT OF POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS AND JUVENILE PSORIATIC ARTHRITIS

* JANSSEN - SUBMISSION OF TWO APPLICATIONS TO U.S. FDA SEEKING APPROVAL OF SIMPONI ARIA BASED ON RESULTS FROM GO-VIVA PHASE 3 CLINICAL TRIAL Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below